Skip to content

Hospice in-patient deep vein thrombosis detection study

HIDDen: Hospice In-patient Deep vein thrombosis Detection study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN97567719
Enrollment
217
Registered
2016-07-15
Start date
2016-06-06
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoral deep vein thrombosis (DVT) in cancer patients admitted to specialist palliative care units (SPCUs). Circulatory System

Interventions

An ultrasound scanner at the hospice bedside, will be used to scan patients’ legs to test whether they have a DVT. Symptoms will be noted, and patients re-scanned a week later. Patients are also asked

Sponsors

University of Hull
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Admitted to a participating SPCU 2. 18 years or older 3. Able to give fully informed written consent or an available nominated consultee 4. No physical limitations to performing the ultrasound assessment

Exclusion criteria

Exclusion criteria: 1. Patients on other clinical trials will be considered on a case by case basis 2. Patients who are considered by the clinical team likely to die within 5 days 3. Where, in the case of a patient without mental capacity, the nominated consultee is too distressed to be approached regarding the study in the opinion of the clinical team 4. Patients unable to understand English well enough to provide informed consent or comply with study assessments

Design outcomes

Primary

MeasureTime frame
The prevalence of femoral DVT in cancer patients admitted to specialist palliative care unit (SPCU) measured by Doppler ultrasound

Secondary

MeasureTime frame
1. Incidence of developing a proximal lower limb DVT in patients with and without a diagnosis of cancer during admission to a SPCU 2. Prevalence of clinical symptoms and signs attributable to VTE (proximal lower limb DVT and PE) on admission to a SPCU 3. Incidence of clinical symptoms and signs attributable to VTE (proximal lower limb DVT and PE) during admission to a SPCU 4. Incidence of acute deterioration or sudden death in patients with a known DVT that could be attributed to clinical pulmonary emboli 5. Clinical characteristics associated with the presence or absence of proximal lower limb DVT 6. Association between use of anticoagulation and presence or absence of DVT on admission and during admission to a SPCU 7. Impact of proximal lower limb DVT on length of stay 8. Survival

Countries

England, Northern Ireland, United Kingdom, Wales

Contacts

Public ContactJohnson Miriam

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 4, 2026